IFN-β treatment modulates the CD28/CTLA-4-mediated pathway for IL-2 production in patients with relapsing-remiting multiple sclerosis

  1. Espejo, C.
  2. Brieva, L.
  3. Ruggiero, G.
  4. Río, J.
  5. Montalban, X.
  6. Martínez-Cáceres, E.M.
Aldizkaria:
Multiple Sclerosis

ISSN: 1352-4585

Argitalpen urtea: 2004

Alea: 10

Zenbakia: 6

Orrialdeak: 630-635

Mota: Artikulua

DOI: 10.1191/1352458504MS1094OA GOOGLE SCHOLAR

Objetivos de desarrollo sostenible

Datuen iturria: Scopus